2) Chemical Diagnostics
Abstract
Focuses on developing state-of-the-art laboratory/fieldable methods that detect exposure to CWA/NTA in clinical samples. Identifies biomolecular targets that can be leveraged as analytical methodologies, as well as, laboratory and animal studies characterizing time-course and longevity of a particular analyte/biomarker. This effort will be realigned in FY19 to TM2 (Techbase Med Defense) Medical Diagnostics.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2019
- Source ID
- df1bb8de2016c542cda6a3cd016b7fc2